[1]
M. Tezer, veysel tosun, and U. Guntekin, “Pulmonary Hypertension Secondary to Dasatinib Use for the Treatment of Chronic Myeloid Leukemia: Pulmonary Hypertension Due to Dasatinib Use”, İJCMBS, vol. 2, no. 2, pp. 153–156, Jul. 2022.